Gene therapy clinical trial pipeline regulatory approval trends: CRISPR to CAR-T Market Dynamics and Regulatory Pathways (2025-2033) The biopharmaceutical landscape is undergoing a profound transformation, driven by the emergence of gene editing and cell-based immunotherapies. The "Gene Therapy Revolution: CRISPR to CAR-T Market Dynamics & Regulatory Pathways 2025-2033" outlines the strategic imperatives for stakeholders operating within or seeking to enter this high-growth sector. This analysis provides…